These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12801372)

  • 21. Treatment of tinea capitis with itraconazole capsule pulse therapy.
    Gupta AK; Hofstader SL; Summerbell RC; Solomon R; Adam P; Alexis M; Raboobee N; De Doncker P
    J Am Acad Dermatol; 1998 Aug; 39(2 Pt 1):216-9. PubMed ID: 9704832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trichophyton rubrum onychomycosis in an 8-week-old infant.
    Khurana VK; Gupta RK; Pant L; Jain S; Chandra K; Sharma Y
    Indian J Dermatol Venereol Leprol; 2011; 77(5):625. PubMed ID: 21860175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fatal hepatitis after long-term pulse itraconazole treatment for onychomycosis.
    Tuccori M; Bresci F; Guidi B; Blandizzi C; Del Tacca M; Di Paolo M
    Ann Pharmacother; 2008 Jul; 42(7):1112-7. PubMed ID: 18523232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An unusual clinical presentation of tinea faciei caused by Trichophyton mentagrophytes var. erinacei.
    Lee DW; Yang JH; Choi SJ; Won CH; Chang SE; Lee MW; Choi JH; Moon KC; Kim MN
    Pediatr Dermatol; 2011; 28(2):210-2. PubMed ID: 21504458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abbreviated oral itraconazole therapy for tinea corporis and tinea cruris.
    Sanmano B; Hiruma M; Mizoguchi M; Ogawa H
    Mycoses; 2003 Sep; 46(8):316-21. PubMed ID: 12950901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tinea corporis due to Trichophyton tonsurans Malmsten--report of a patient from Zaire.
    Nenoff P; Haustein UF
    Mycoses; 1997 Sep; 40(3-4):127-9. PubMed ID: 9375501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of disseminated onychomycosis due to Trichophyton rubrum with itraconazole under control of plasma levels.
    Schrenker T; Koch HU
    Mycoses; 1991; 34(7-8):331-2. PubMed ID: 1666425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Limits of brief treatment of onychomycoses].
    Seebacher C
    Hautarzt; 1998 Sep; 49(9):705-8. PubMed ID: 9794158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in serum chemistry values in shelter cats treated with 21 consecutive days of oral itraconazole for dermatophytosis.
    Moriello KA; Verbrugge M
    Vet Dermatol; 2013 Oct; 24(5):557-8. PubMed ID: 23889285
    [No Abstract]   [Full Text] [Related]  

  • 30. Deep Dermatophytosis Caused by Zoophilic Strain of Trichophyton interdigitale with Successful Treatment of Itraconazole.
    Su HA; Sun PL; Sung WW; Cheng SY; Chang HC; Yang JH; Hsiao YP
    Mycopathologia; 2017 Aug; 182(7-8):715-720. PubMed ID: 28154954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Naftifine treatment of resistant dermatophytosis.
    Rosen T; Fischer M; Orengo I; Abuabara F
    Int J Dermatol; 1991 Aug; 30(8):590-2. PubMed ID: 1938060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fungal melanonychia caused by Trichophyton rubrum and the value of dermoscopy.
    Wang YJ; Sun PL
    Cutis; 2014 Sep; 94(3):E5-6. PubMed ID: 25279488
    [No Abstract]   [Full Text] [Related]  

  • 33. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
    Gupta AK; Gregurek-Novak T
    Dermatology; 2001; 202(3):235-8. PubMed ID: 11385230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of onychomycosis and tinea pedis with intermittent itraconazole therapy.
    Del Rosso JQ
    J Am Osteopath Assoc; 1996 Oct; 96(10):607-9. PubMed ID: 8936929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of dermatomycoses with a new antimycotic: itraconazole. Comparative studies of 2 posologic regimens].
    Cervetti O; Forte M
    G Ital Dermatol Venereol; 1987 Nov; 122(11):LXI-LXIII. PubMed ID: 2834292
    [No Abstract]   [Full Text] [Related]  

  • 36. Randomized, placebo-controlled, phase 3 study of itraconazole for the treatment of onychomycosis.
    Maddin S; Quiring J; Bulger L
    J Drugs Dermatol; 2013 Jul; 12(7):758-63. PubMed ID: 23884486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Economic evaluation of antifungal agents in the treatment of toenail onychomycosis in Germany.
    Van Doorslaer EK; Tormans G; Gupta AK; Van Rossem K; Eggleston A; Dubois DJ; De Doncker P; Haneke E
    Dermatology; 1996; 193(3):239-44. PubMed ID: 8944348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral antifungal-exacerbated inflammatory flare-up reactions of dermatomycosis : case reports and review of the literature.
    Nikkels AF; Nikkels-Tassoudji N; Piérard GE
    Am J Clin Dermatol; 2006; 7(5):327-31. PubMed ID: 17007544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of itraconazole and griseofulvin in the treatment of tinea corporis and tinea cruris: a double-blind study.
    Panagiotidou D; Kousidou T; Chaidemenos G; Karakatsanis G; Kalogeropoulou A; Teknetzis A; Chatzopoulou E; Michailidis D
    J Int Med Res; 1992 Sep; 20(5):392-400. PubMed ID: 1333423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Double-blind comparison of itraconazole with griseofulvin in the treatment of tinea pedis and tinea manuum.
    Van Hecke E; Van Cutsem J
    Mycoses; 1988 Dec; 31(12):641-9. PubMed ID: 2852776
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.